VPC-13789
VPC-13789 is a potent, selective, and orally bioavailable antiandrogen. VPC-13789 can be used for the research of castration-resistant prostate cancer (CRPC) therapeutics. VPC-13789 inhibits androgen receptor (AR) transcriptional activity in LNCaP cells (IC50=0.19 μM) [1].
Product Specifications
CAS Number
2761146-51-2
UNSPSC
12352005
Target
Androgen Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/vpc-13789.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=C2C=CC(C3=CNC4=C3C=C(F)C(F)=C4F)=NC2=CC=C1)NC(C)C
Molecular Formula
C21H16F3N3O
Molecular Weight
383.37
References & Citations
[1]Eric Leblanc , et al. Development of 2- (5,6,7-Trifluoro-1 H-Indol-3-yl) -quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer. J Med Chem. 2021 Oct 28;64 (20) :14968-14982.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC228514L4 10 µg
SLC13A2 (NM_001145975) Human Tagged Lenti ORF Clone
Sign In for Pricing
View Details QP7609-ec-50ug 50ug
Recombinant Human Sorting nexin-1 Protein, His-SUMO, E.coli-50ug
Sign In for Pricing
View Details